261 related articles for article (PubMed ID: 25368228)
1. Effect of radiation on cell proliferation and tumor hypoxia in HPV-positive head and neck cancer in vivo models.
Sørensen BS; Busk M; Horsman MR; Alsner J; Overgaard J; Kyle AH; Minchinton AI
Anticancer Res; 2014 Nov; 34(11):6297-304. PubMed ID: 25368228
[TBL] [Abstract][Full Text] [Related]
2. Radiosensitivity and effect of hypoxia in HPV positive head and neck cancer cells.
Sørensen BS; Busk M; Olthof N; Speel EJ; Horsman MR; Alsner J; Overgaard J
Radiother Oncol; 2013 Sep; 108(3):500-5. PubMed ID: 23953409
[TBL] [Abstract][Full Text] [Related]
3. Radiation-Induced Dedifferentiation of Head and Neck Cancer Cells Into Cancer Stem Cells Depends on Human Papillomavirus Status.
Vlashi E; Chen AM; Boyrie S; Yu G; Nguyen A; Brower PA; Hess CB; Pajonk F
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1198-206. PubMed ID: 27026319
[TBL] [Abstract][Full Text] [Related]
4. Crizotinib Fails to Enhance the Effect of Radiation in Head and Neck Squamous Cell Carcinoma Xenografts.
Baschnagel AM; Galoforo S; Thibodeau BJ; Ahmed S; Nirmal S; Akervall J; Wilson GD
Anticancer Res; 2015 Nov; 35(11):5973-82. PubMed ID: 26504020
[TBL] [Abstract][Full Text] [Related]
5. Experimental investigation of radiobiology in head and neck cancer cell lines as a function of HPV status, by MTT assay.
Reid P; Wilson P; Li Y; Marcu LG; Staudacher AH; Brown MP; Bezak E
Sci Rep; 2018 May; 8(1):7744. PubMed ID: 29773816
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapeutic alteration of VEGF-/PDGF- and PDGF-Rα/β expression by imatinib in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
Schultz JD; Mühlheim K; Erben P; Hofheinz RD; Faber A; Thorn C; Sommer JU; Hörmann K; Sauter A
Oncol Rep; 2011 Nov; 26(5):1099-109. PubMed ID: 21805039
[TBL] [Abstract][Full Text] [Related]
7. Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer.
Spanos WC; Nowicki P; Lee DW; Hoover A; Hostager B; Gupta A; Anderson ME; Lee JH
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1137-46. PubMed ID: 19917928
[TBL] [Abstract][Full Text] [Related]
8. Treatment response of HPV-positive and HPV-negative head and neck squamous cell carcinoma cell lines.
Nagel R; Martens-de Kemp SR; Buijze M; Jacobs G; Braakhuis BJ; Brakenhoff RH
Oral Oncol; 2013 Jun; 49(6):560-6. PubMed ID: 23578372
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapeutic alteration of VEGF, PDGF and PDGFRα/β expression under 5-FU vs. docetaxel in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
Aderhold C; Umbreit C; Faber A; Sauter A; Sommer JU; Birk R; Erben P; Hofheinz RD; Stern-Straeter J; Hörmann K; Schultz JD
Anticancer Res; 2013 May; 33(5):1951-61. PubMed ID: 23645743
[TBL] [Abstract][Full Text] [Related]
10. Unravelling the biology of human papillomavirus (HPV) related tumours to enhance their radiosensitivity.
Vozenin MC; Lord HK; Hartl D; Deutsch E
Cancer Treat Rev; 2010 Dec; 36(8):629-36. PubMed ID: 20417037
[TBL] [Abstract][Full Text] [Related]
11. Differential anticancer activities of arsenic trioxide on head and neck cancer cells with different human papillomavirus status.
Du S; Liu K; Gao P; Li Z; Zheng J
Life Sci; 2018 Nov; 212():182-193. PubMed ID: 30243648
[TBL] [Abstract][Full Text] [Related]
12. HSV-1 Infection Modulates the Radioresponse of a HPV16-positive Head and Neck Cancer Cell Line.
Turunen A; Hukkanen V; Kulmala J; Syrjanen S
Anticancer Res; 2016 Feb; 36(2):565-74. PubMed ID: 26851010
[TBL] [Abstract][Full Text] [Related]
13. TRIP12 as a mediator of human papillomavirus/p16-related radiation enhancement effects.
Wang L; Zhang P; Molkentine DP; Chen C; Molkentine JM; Piao H; Raju U; Zhang J; Valdecanas DR; Tailor RC; Thames HD; Buchholz TA; Chen J; Ma L; Mason KA; Ang KK; Meyn RE; Skinner HD
Oncogene; 2017 Feb; 36(6):820-828. PubMed ID: 27425591
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck.
Ringström E; Peters E; Hasegawa M; Posner M; Liu M; Kelsey KT
Clin Cancer Res; 2002 Oct; 8(10):3187-92. PubMed ID: 12374687
[TBL] [Abstract][Full Text] [Related]
15. Similar cisplatin sensitivity of HPV-positive and -negative HNSCC cell lines.
Busch CJ; Becker B; Kriegs M; Gatzemeier F; Krüger K; Möckelmann N; Fritz G; Petersen C; Knecht R; Rothkamm K; Rieckmann T
Oncotarget; 2016 Jun; 7(24):35832-35842. PubMed ID: 27127883
[TBL] [Abstract][Full Text] [Related]
16. A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
Foy JP; Bazire L; Ortiz-Cuaran S; Deneuve S; Kielbassa J; Thomas E; Viari A; Puisieux A; Goudot P; Bertolus C; Foray N; Kirova Y; Verrelle P; Saintigny P
BMC Med; 2017 Sep; 15(1):165. PubMed ID: 28859688
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus in head and neck cancer: molecular biology and clinicopathological correlations.
Szentirmay Z; Pólus K; Tamás L; Szentkuti G; Kurcsics J; Csernák E; Tóth E; Kásler M
Cancer Metastasis Rev; 2005 Jan; 24(1):19-34. PubMed ID: 15785870
[TBL] [Abstract][Full Text] [Related]
18. Biological basis for increased sensitivity to radiation therapy in HPV-positive head and neck cancers.
Bol V; Grégoire V
Biomed Res Int; 2014; 2014():696028. PubMed ID: 24804233
[TBL] [Abstract][Full Text] [Related]
19. Detection of human papillomavirus-related squamous cell carcinoma cytologically and by in situ hybridization in fine-needle aspiration biopsies of cervical metastasis: a tool for identifying the site of an occult head and neck primary.
Zhang MQ; El-Mofty SK; Dávila RM
Cancer; 2008 Apr; 114(2):118-23. PubMed ID: 18300234
[TBL] [Abstract][Full Text] [Related]
20. Human Papilloma Virus as a Biomarker for Personalized Head and Neck Cancer Radiotherapy.
Eriksen JG; Lassen P
Recent Results Cancer Res; 2016; 198():143-61. PubMed ID: 27318685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
